| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2001;72:1691-1697
© 2001 The Society of Thoracic Surgeons
a Department of Surgery, Budapest, Hungary
b Anesthesiology and Intensive Care Unit, Buda MÁV Hospital, Budapest, Hungary
c Department of Neurology, South-Pest County and Teaching Hospital, Budapest, Hungary
Accepted for publication June 23, 2001.
* Address reprint requests to Dr Kas, Buda MÁV Hospital, Szanatórium u 2/a, H-1528 Budapest, Hungary
e-mail: kasaczel{at}matavnet.hu
Background. We studied the incidences and evaluated the management of early postoperative complications after thymectomy for myasthenia gravis.
Methods. During the period between 1987 and 1996, 324 thymectomies were performed through median sternotomy access under general anesthesia. Postoperative management was administered according to a standardized protocol of anticholinesterase medication, which was withdrawn for the 48 hours of obligatory postoperative mechanical ventilation. The mean age of patients was 34 years (range, 8 to 71 years).
Results. One hundred forty-nine patients made an uneventful recovery; 104 patients had only minor complications, whereas 71 patients had major complications. The mortality rate was 0.6% (2 patients). The major surgical complications were recorded as sternal bleeding (1 patient) and sternal disruption (1 patient). The major general complications were recorded as tracheal stenosis (1 patient), pneumonia (3 patients), heart failure (1 patient), gastric hemorrhage (1 patient), and respiratory insufficiency (71 patients). Forty-six reintubations were performed on 40 patients and 19 tracheostomies (6%) were performed postoperatively.
Conclusions. The excessive incidence of respiratory insufficiency and airway-associated morbidity was potentially related, at least partially, to prolonged mechanical ventilation and withdrawal of anticholinesterase medication. Earlier weaning of patients with revision of 48-hour withdrawal of anticholinesterase medication is necessary.
This article has been cited by other articles:
|
|
 |
|
  J. B. Shrager, D. Nathan, C. J. Brinster, O. Yousuf, A. Spence, Z. Chen, and L. R. Kaiser Outcomes After 151 Extended Transcervical Thymectomies for Myasthenia Gravis Ann. Thorac. Surg., November 1, 2006; 82(5): 1863 - 1869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sekine, N. Kawaguchi, C. Hamada, H. Sekiguchi, K. Yasufuku, A. Iyoda, K. Shibuya, and T. Fujisawa Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis? Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 908 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Boseila Reply to Zielinski and Kuzdzal Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 504 - 505. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Watanabe, T. Watanabe, T. Obama, T. Mawatari, H. Ohsawa, Y. Ichimiya, N. Takahashi, K. Kusajima, and T. Abe Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 868 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S Singh, S. K Behera, R. Saji, and R. S Dhaliwal Thymectomy for Myasthenia Gravis: 12-Year Experience Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 299 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jaretzki III, J. A. Aarli, H. J. Kaminski, L. H. Phillips II, and D. B. Sanders Preoperative preparation of patients with myasthenia gravis forestalls postoperative respiratory complications after thymectomy Ann. Thorac. Surg., March 1, 2003; 75(3): 1068 - 1068. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
